Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision?
In the last few years, we published two special issues devoted to highlighting important scientific results in the field of bladder cancer research and clinical implications [...]
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/24/9657 |
id |
doaj-9c599566494942659de1a35c0879b3e9 |
---|---|
record_format |
Article |
spelling |
doaj-9c599566494942659de1a35c0879b3e92020-12-19T00:00:32ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-12-01219657965710.3390/ijms21249657Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision?Thorsten H. Ecke0Thomas Otto1Florence Le Calvez-Kelm2Department of Urology, HELIOS Hospital Bad Saarow, DE-15526 Bad Saarow, GermanyDepartment of Urology, Rheinland Klinikum Neuss, DE-41464 Neuss, GermanyInternational Agency for Research on Cancer (IARC), F-69372 Lyon, FranceIn the last few years, we published two special issues devoted to highlighting important scientific results in the field of bladder cancer research and clinical implications [...]https://www.mdpi.com/1422-0067/21/24/9657n/a |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Thorsten H. Ecke Thomas Otto Florence Le Calvez-Kelm |
spellingShingle |
Thorsten H. Ecke Thomas Otto Florence Le Calvez-Kelm Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision? International Journal of Molecular Sciences n/a |
author_facet |
Thorsten H. Ecke Thomas Otto Florence Le Calvez-Kelm |
author_sort |
Thorsten H. Ecke |
title |
Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision? |
title_short |
Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision? |
title_full |
Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision? |
title_fullStr |
Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision? |
title_full_unstemmed |
Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision? |
title_sort |
evaluating the utility of combined bladder cancer biomarkers, the molecular prognostication of tumor subtypes, or what else is needed to illuminate our vision? |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2020-12-01 |
description |
In the last few years, we published two special issues devoted to highlighting important scientific results in the field of bladder cancer research and clinical implications [...] |
topic |
n/a |
url |
https://www.mdpi.com/1422-0067/21/24/9657 |
work_keys_str_mv |
AT thorstenhecke evaluatingtheutilityofcombinedbladdercancerbiomarkersthemolecularprognosticationoftumorsubtypesorwhatelseisneededtoilluminateourvision AT thomasotto evaluatingtheutilityofcombinedbladdercancerbiomarkersthemolecularprognosticationoftumorsubtypesorwhatelseisneededtoilluminateourvision AT florencelecalvezkelm evaluatingtheutilityofcombinedbladdercancerbiomarkersthemolecularprognosticationoftumorsubtypesorwhatelseisneededtoilluminateourvision |
_version_ |
1724378237394485248 |